US physical therapy COO Graham Reeve sells $142,050 in stock

Published 08/03/2025, 02:32
US physical therapy COO Graham Reeve sells $142,050 in stock

Graham Reeve, Chief Operating Officer of U.S. Physical Therapy Inc. (NYSE:USPH), has recently sold 1,730 shares of the company’s common stock. The sale was executed on March 7, 2025, at a price of $82.11 per share, amounting to a total transaction value of $142,050. The transaction comes as the $1.2 billion market cap company trades near its 52-week low of $76.18, with InvestingPro analysis indicating the stock is currently fairly valued.

Following this transaction, Reeve holds 7,168 shares indirectly through the Reeve Trust. Additionally, he retains direct ownership of 19,192 shares, which includes restricted shares granted under the company’s Amended and Restated 2003 Stock Incentive Plan. These restricted shares are scheduled to vest in various tranches through 2029, contingent upon continued employment. For deeper insights into USPH’s insider transactions and comprehensive financial analysis, investors can access the detailed Pro Research Report available on InvestingPro.

This recent sale by Reeve is part of his ongoing management of his holdings in the company. The stock currently offers a 2.23% dividend yield and has maintained dividend payments for 15 consecutive years, demonstrating consistent shareholder returns despite trading at a relatively high P/E ratio of 44.8x.

In other recent news, U.S. Physical Therapy reported its fourth-quarter 2024 earnings, posting an earnings per share (EPS) of $0.52, which fell short of the anticipated $0.69. However, the company surpassed revenue expectations, achieving $180.45 million, slightly above the forecasted $174.79 million. The revenue growth was driven by a 14.2% year-over-year increase in physical therapy revenues and the addition of approximately 70 clinics. Despite the revenue success, the EPS miss has raised concerns about future earnings, particularly in light of anticipated Medicare rate reductions. The company expects EBITDA for 2025 to range between $88 million and $93 million, with potential impacts from a 2.9% Medicare rate cut. U.S. Physical Therapy is also focusing on expanding home-based therapy services and virtual staffing to navigate these challenges. Additionally, analysts from Jefferies have highlighted the company’s strategic focus on increasing reimbursement rates. The firm is actively working on rate negotiations and payer contract adjustments to mitigate financial challenges.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.